Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H17Cl2N3O4S |
InChIKeyLXTDDWSYQKHDKA-UHFFFAOYSA-N |
CAS Registry2891459-48-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acinetobacter Baumannii Infection | Preclinical | Slovenia | 12 Jan 2023 | |
| Pseudomonas aeruginosa infection | Preclinical | Slovenia | 12 Jan 2023 |





